缓解良性前列腺增生后的下尿道症状:改善老年男性的性功能和心理健康
Alex Siu Wing Chan1, Steve Wai Hee Chan2, Anelise Gregis Estivalet3
1Department of Applied Social Sciences, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong.
American journal of men's health
|December 14, 2023
概括
患有良性前列腺增生症 (BPH) 的老年男性下泌尿道症状 (LUTS) 对性功能和心理健康产生负面影响. 改善前列腺健康可以提高福祉和生活质量.
科学领域:
- 老年学是一门学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 男人的健康 男人健康
背景情况:
- 良性前列腺增生症 (BPH) 在老年男性中很常见.
- 与BPH相关的下尿路症状 (LUTS) 可以显著影响生活质量.
- LUTS对性功能和心理健康的影响需要进一步研究.
研究的目的:
- 为了确定LUTS在BPH老年男性的患病率.
- 检查LUTS对性功能和心理健康的影响.
- 探索前列腺健康,LUTS,性功能和心理健康之间的关系.
主要方法:
- 使用了描述性,相关性和回归分析.
- 从3056名患有BPH的老年男性的队列中收集了数据.
- 使用统计方法来评估LUTS和前列腺健康的影响.
主要成果:
- 发现LUTS对性功能和心理健康产生不利影响.
- 更好的前列腺和下泌尿道健康状况对心理健康产生了积极的影响.
- 性功能也与心理健康有着积极的关联.
结论:
- 在BPH老年男性中,对LUTS的早期干预至关重要.
- 解决前列腺和下泌尿道健康问题可以改善心理健康.
- 医疗保健专业人员应该考虑BPH和LUTS对男性生活质量的综合影响.
相关概念视频
Disorders of the Male Reproductive System
422
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
422
Menopause
170
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
170
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
161
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
161
Male Sexual Response: Erection & Ejaculation
2.5K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
2.5K
Antihypertensive Drugs: Vasodilators
532
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
532
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
833
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
833


